Merck & Co. (MRK)
(Delayed Data from NYSE)
$131.20 USD
+0.48 (0.37%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $131.20 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Income Statements
Fiscal Year end for Merck & Co, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 60,115 | 59,283 | 48,704 | 47,994 | 46,840 |
Cost Of Goods | 16,126 | 17,411 | 13,626 | 15,485 | 14,112 |
Gross Profit | 43,989 | 41,872 | 35,078 | 32,509 | 32,728 |
Selling & Adminstrative & Depr. & Amort Expenses | 41,035 | 23,590 | 21,879 | 24,026 | 20,487 |
Income After Depreciation & Amortization | 2,954 | 18,282 | 13,199 | 8,483 | 12,241 |
Non-Operating Income | -1,065 | -1,838 | 680 | 308 | -777 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 1,889 | 16,444 | 13,879 | 8,791 | 11,464 |
Income Taxes | 1,512 | 1,918 | 1,521 | 1,709 | 1,687 |
Minority Interest | 12 | 7 | 13 | 15 | -66 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 377 | 14,526 | 12,358 | 7,082 | 9,777 |
Extras & Discontinued Operations | 0 | 0 | 704 | 0 | 0 |
Net Income (GAAP) | 365 | 14,519 | 13,049 | 7,067 | 9,843 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 6,826 | 22,191 | 16,413 | 12,108 | 15,893 |
Depreciation & Amortization (Cash Flow) | 3,872 | 3,909 | 3,214 | 3,625 | 3,652 |
Income After Depreciation & Amortization | 2,954 | 18,282 | 13,199 | 8,483 | 12,241 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 2,547.00 | 2,542.00 | 2,538.00 | 2,541.00 | 2,580.00 |
Diluted EPS Before Non-Recurring Items | 1.51 | 7.48 | 6.02 | 5.94 | 5.19 |
Diluted Net EPS (GAAP) | 0.14 | 5.71 | 5.14 | 2.78 | 3.81 |
Fiscal Year end for Merck & Co, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 14,631.00 | 15,962.00 | 15,035.00 | 14,487.00 |
Cost Of Goods | NA | 3,912.00 | 4,264.00 | 4,024.00 | 3,926.00 |
Gross Profit | NA | 10,719.00 | 11,698.00 | 11,011.00 | 10,561.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 12,431.00 | 5,826.00 | 16,023.00 | 6,755.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -1,712.00 | 5,872.00 | -5,012.00 | 3,806.00 |
Non-Operating Income | NA | -334.00 | -252.00 | -323.00 | -156.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -2,046.00 | 5,620.00 | -5,335.00 | 3,650.00 |
Income Taxes | NA | -820.00 | 870.00 | 637.00 | 825.00 |
Minority Interest | NA | 0.00 | 5.00 | 3.00 | 4.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -1,226.00 | 4,750.00 | -5,972.00 | 2,825.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -1,226.00 | 4,745.00 | -5,975.00 | 2,821.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 2,533.00 | 2,546.00 | 2,539.00 | 2,551.00 |
Diluted EPS Before Non-Recurring Items | NA | 0.03 | 2.13 | -2.06 | 1.40 |
Diluted Net EPS (GAAP) | NA | -0.48 | 1.86 | -2.35 | 1.11 |